Announcing strategic partnership : SyrHA the CDMO and ISHAS organization

We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic Acid Science (ISHAS) as an inaugural member of the Advisory Board (AAB). ISHAS is a prestigious organization whose mission is to promote research, organize the publication of scientific reports and disseminate knowledge about the hyaluronic acid molecule, its structure, function, and therapeutic applications.

This partnership is more than just a strategic collaboration. ISHAS will benefit from SyrHA’s practical industry experience as a biotech medical device company and as a global leader in providing innovative medical devices solutions for aesthetics, orthopedics, ophthalmology, and dermatology. SyrHA stands to gain substantial benefits from engaging with top-tier research and a prominent expert network. 

By leveraging the synergy between state-of-the-art research and a global community of experts, SyrHA can consolidate its leadership position in the CDMO world, delivering exceptional value to its customers and stakeholders. 

Collaboration with leading scientists and researchers will foster the development of new products and services, and enhance existing ones, ensuring that SyrHA remains at the forefront of progress. Moreover, integration into a network of international experts provides an invaluable exchange of ideas, access to a wider range of specialist knowledge, and the opportunity to form strategic partnerships. These collaborations will improve efficiency, optimize manufacturing processes and create more sophisticated products.

Learn more about this initiative:

 SyrHA is specialized in the manufacture of medical devices, in the form of pre-filled syringes. We are a Swiss CDMO, and we manufacture aesthetic medical devices.

We also develop hydrogel products for orthopedics, ophthalmology and dermatology. 

Do you have a project?

Explore our environment

  • Company

    They Trust SyrHA : The Excellence of a CDMO

    At SyrHA, we believe that the cornerstone of our success is the unwavering trust that…

    Clients testimonials
  • Company

    Announcing strategic partnership : SyrHA the CDMO and ISHAS organization

    We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic…

  • Company

    CDMO: Evolution of their role

    Innovative biopharmaceutical companies are increasingly engaging in strategic partnerships with CDMOs, whereas in the past,…

    CDMO: Evolution of their role
  • Company

     Join us at IMCAS Paris! 

    We’re delighted to announce that our team will be taking part in the IMCAS 2024…

    IMCAS 2024 World Congress in Paris
  • Company

    SyrHATech is thrilled to install its new autoclave!

    In the field of sterile medical device manufacturing, the terminal sterilization of your products is…

    SyrHATech new autoclave
  • Company

    SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

    The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…

    CPHI Barcelona 2023
  • Company

    Inauguration of Syrhatech’s new premises in Geneva

    The Syrhatech team was delighted to share a convivial moment on its terrace on the…

    Inauguration of Syrhatech's new premises in Geneva
  • Company

    Development of a specific syringe for wrinkle filler

    Our customer contacts us to validate the design of a syringe made of plastic by…

  • Company

    Development of an innovative gel with very high concentration

    Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…

  • Company

    Technology transfer

    Our team relies on its many years of experience and past successes, to prepare and…

    Syrhatech - technology transfer